Americanii de Abbott Laboratories platesc 4,5 mld. euro pentru Solvay
Producatorul american de medicamente Abbott Laboratories a anuntat luni ca va cumpara unitatea de medicamente cu prescriptie a companiei belgiene Solvay printr-o tranzactie estimata la 4,5 mld. euro, potrivit New York Times.
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2009/09/4ac0a389b3711.jpg)
Prin achizitia afacerii farmaceutice a Solvay, Abbott va avea control total asupra pastilei pentru colesterol TriCor, care a generat vanzari de peste 1,3 mld. dolari in anul trecut.
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/themes/strawberry-daily-202207/assets/images/avatar.png){kind=avatar}
Alte articole
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/06/Trump_cripto.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/06/munca-de-acasa.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/06/Visa-Payments-Forum.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/06/disponibilizari-concedieri-20230-Volkswagen.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2024/12/elevi-1.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/06/caietul-lui-Mozart.jpeg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/06/desert-1.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/06/Jeppe-Bruus.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/09/Venetia.jpg)
